Influence of pharmaceutical factors on the dissolution profile of granules for oral suspension with nimesulide

К. В. Тарапон, О. В. Тригубчак
{"title":"Influence of pharmaceutical factors on the dissolution profile of granules for oral suspension with nimesulide","authors":"К. В. Тарапон, О. В. Тригубчак","doi":"10.32352/0367-3057.3.22.07","DOIUrl":null,"url":null,"abstract":"In vitro dissolution profiles are investigated to predict the behavior of the drug in the body and to establish its effectiveness. The choice of medium and dissolution conditions depends on the class of BSC of the active substance or substances that are part of the drug. In this work, nimesulide was chosen as a model substance, which is a sparingly soluble substance of class II BSC, when bioavailability is limited only by dissolution. \nThe aim of the work was to establish optimal conditions for determining the dissolution profiles of Nimesulide, granules for oral solution, 100 mg/2 g and to study the effect of compositional variables on the release of API. \nThe subject of the study was granules for oral suspension, made on the basis of nimesulide. In the experiment used the substance nimesulide 3 manufacturers, corn starch and macrogol 20 (polyethylene glycol) cetostearyl ether. The particle size of the substances was investigated by laser diffraction. Determination of nimesulide release was performed by HPLC. \nThe results of the study of the dissolution profiles of the drug Aulin, granules for oral suspension in pH 6.8, 7.5 and 7.8, where the active substance is not completely released. The addition of surfactants was used to increase the solubility of the drug. It has been experimentally confirmed that when using API nimesulide with a particle size D (90) = 64 μm, the release profiles are below the comparison drug. The similarity of the dissolution profiles of the test agent and the comparison drug provide API with a particle size D (90) < 30 μm. The dependence of the dissolution profile on the amounts of corn starch and macrogol 20 (polyethylene glycol) of cetostearyl ether is given, their optimal content in the composition of the drug is established. \nIn the result of the work, the influence of research conditions on the dissolution profile of Aulin, granules for oral suspension, 100 mg/2 g was studied. pH 6.8 + 1% tween 80 and pH 7.4 + 0.5% tween 80 were chosen as optimal media. Experiments showed that the particle size of API nimesulide D (90) < 30 μm ensures compliance with the drug Nimesulide, granules for oral suspension, 100 mg/2 g by dissolution profiles. Increasing the amount of corn starch in the composition of the drug accelerates the dissolution of the granules and, as a consequence, raises the first points of the release profile of API. The use of 0.5% corn starch provides the dissolution profile closest to the comparison drug. To completely release API as a solubilizer, it is advisable to add 1% macrogol 20 (polyethylene glycol) cetostearyl ether.","PeriodicalId":32942,"journal":{"name":"Farmatsevtichnii zhurnal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmatsevtichnii zhurnal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32352/0367-3057.3.22.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In vitro dissolution profiles are investigated to predict the behavior of the drug in the body and to establish its effectiveness. The choice of medium and dissolution conditions depends on the class of BSC of the active substance or substances that are part of the drug. In this work, nimesulide was chosen as a model substance, which is a sparingly soluble substance of class II BSC, when bioavailability is limited only by dissolution. The aim of the work was to establish optimal conditions for determining the dissolution profiles of Nimesulide, granules for oral solution, 100 mg/2 g and to study the effect of compositional variables on the release of API. The subject of the study was granules for oral suspension, made on the basis of nimesulide. In the experiment used the substance nimesulide 3 manufacturers, corn starch and macrogol 20 (polyethylene glycol) cetostearyl ether. The particle size of the substances was investigated by laser diffraction. Determination of nimesulide release was performed by HPLC. The results of the study of the dissolution profiles of the drug Aulin, granules for oral suspension in pH 6.8, 7.5 and 7.8, where the active substance is not completely released. The addition of surfactants was used to increase the solubility of the drug. It has been experimentally confirmed that when using API nimesulide with a particle size D (90) = 64 μm, the release profiles are below the comparison drug. The similarity of the dissolution profiles of the test agent and the comparison drug provide API with a particle size D (90) < 30 μm. The dependence of the dissolution profile on the amounts of corn starch and macrogol 20 (polyethylene glycol) of cetostearyl ether is given, their optimal content in the composition of the drug is established. In the result of the work, the influence of research conditions on the dissolution profile of Aulin, granules for oral suspension, 100 mg/2 g was studied. pH 6.8 + 1% tween 80 and pH 7.4 + 0.5% tween 80 were chosen as optimal media. Experiments showed that the particle size of API nimesulide D (90) < 30 μm ensures compliance with the drug Nimesulide, granules for oral suspension, 100 mg/2 g by dissolution profiles. Increasing the amount of corn starch in the composition of the drug accelerates the dissolution of the granules and, as a consequence, raises the first points of the release profile of API. The use of 0.5% corn starch provides the dissolution profile closest to the comparison drug. To completely release API as a solubilizer, it is advisable to add 1% macrogol 20 (polyethylene glycol) cetostearyl ether.
药物因素对尼美舒利口服混悬剂颗粒溶出度的影响
研究了体外溶出谱,以预测药物在体内的行为并确定其有效性。介质和溶出条件的选择取决于活性物质的BSC类别或作为药物一部分的物质。在这项工作中,尼美舒利被选为模型物质,它是一种II类BSC的微溶性物质,当生物利用度仅受溶解限制时。本工作的目的是建立测定口服溶液用尼美舒利颗粒(100 mg/2 g)溶出度的最佳条件,并研究成分变量对API释放的影响。研究对象是在尼美舒利的基础上制备的口服悬浮颗粒。在实验中使用的物质是尼美舒利3个生产商,玉米淀粉和聚乙二醇20(聚乙二醇)鲸蜡硬脂基醚。通过激光衍射研究了这些物质的粒度。采用高效液相色谱法测定尼美舒利的释放度。药物Aulin的溶出曲线的研究结果,用于pH 6.8、7.5和7.8的口服悬浮液颗粒,其中活性物质未完全释放。表面活性剂的加入被用来增加药物的溶解度。实验证实,当使用粒径D(90)=64μm的API尼美舒利时,释放曲线低于对照药物。试验剂和对照药物的溶出曲线相似,为API提供了粒径D(90)<30μm的样品。给出了玉米淀粉和聚乙二醇20(聚乙二醇)十六烷芳基醚用量对药物溶出度的依赖性,确定了它们在药物组成中的最佳含量。在研究结果中,研究了研究条件对口服混悬剂Aulin颗粒(100mg/2g)溶出度的影响。选择pH6.8+1%吐温80和pH7.4+0.5%吐温80为最佳培养基。实验表明,API尼美舒利D(90)的粒径<30μm可确保符合药物尼美舒利口服混悬剂颗粒100 mg/2 g的溶出度。增加药物成分中玉米淀粉的量会加速颗粒的溶解,因此,提高API释放曲线的第一点。0.5%玉米淀粉的使用提供了最接近比较药物的溶出曲线。为了完全释放API作为增溶剂,建议添加1%聚乙二醇20(聚乙二醇)鲸蜡基芳基醚。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
43
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书